Breaking News Instant updates and real-time market news.

SAGE

Sage Therapeutics

$177.38

-2.52 (-1.40%)

16:28
02/07/18
02/07
16:28
02/07/18
16:28

Sage Therapeutics announces $575M common stock offering

Sage Therapeutics announced that it has commenced an underwritten public offering of $575M of its common stock. Sage also intends to grant the underwriters a 30-day option to purchase up to an additional $86.3M of its common stock offered in the public offering. All of the shares in the offering are to be sold by Sage. J.P. Morgan, Goldman Sachs and Morgan Stanley are acting as joint book-running managers for the offering. The offering is subject to market and other conditions.

  • 30

    May

SAGE Sage Therapeutics
$177.38

-2.52 (-1.40%)

12/08/17
NEED
12/08/17
NO CHANGE
Target $193
NEED
Buy
Sage Therapeutics price target raised to $193 from $100 at Needham
Needham analyst Danielle Brill raised her price target on Sage Therapeutics to $193 following positive Phase 2 results of SAGE-217 in major depressive disorder cases. Brill says that given the "clear and consistent benefit" of the treatment, she has "increased confidence that '217 may have utility in a broad spectrum of mood disorders". In addition to reaching "blockbuster status", the analyst contends that '217 raises the possibility of a near term M&A approach from big pharma.
12/08/17
RAJA
12/08/17
NO CHANGE
Target $206
RAJA
Strong Buy
Sage Therapeutics price target raised to $206 from $109 at Raymond James
Raymond James analyst Laura Chico raised Sage Therapeutics' price target to $206 following positive Phase 2 results of SAGE-217 in major depressive disorder cases. Chico raised her prior market share and probability of success assumptions, as well as adding credit in postpartum depression and thinks the update de-risks that program. The analyst has a Strong Buy rating on Sage shares.
12/08/17
BMOC
12/08/17
NO CHANGE
Target $203
BMOC
Outperform
Sage Therapeutics price target raised to $203 from $112 at BMO Capital
BMO Capital analyst Gary Nachman raised his price target on Sage Therapeutics to $203 and kept his Outperform rating after releasing Phase 2 SAGE-217 major depressive disorder data that "transforms the company". Nachman says he sees high probability of success for the treatment as it progresses to larger Phase 3 studies and calls it a "game changer" in the very large major depressive disorder / post-partum depression markets. The analyst also says the company remains an "attractive acquisition candidate".
01/31/18
BMOC
01/31/18
NO CHANGE
Target $203
BMOC
Outperform
Sage data support exploring sleep disorders, says BMO Capital
In a relatively small proof-of-concept study, SAGE-217 demonstrated a potential benefit in improving sleep, BMO Capital analyst Gary Nachman tells investors in a research note. These data support Sage Therapeutics exploring SAGE-217 for sleep disorders, the analyst adds. He believes validation for sleep disorders opens up the product to a "whole other large therapeutic area that could drive further upside." Nachman reiterates an Outperform rating on Sage with a $203 price target. The stock in morning trading is up 2.5% to $189.21.

TODAY'S FREE FLY STORIES

VIPS

Vipshop

$11.65

0.425 (3.79%)

15:25
06/18/18
06/18
15:25
06/18/18
15:25
Options
Vipshop call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

TFX

Teleflex

$280.29

-1.61 (-0.57%)

15:20
06/18/18
06/18
15:20
06/18/18
15:20
Conference/Events
Teleflex management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 21

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

  • 05

    Sep

GME

GameStop

$14.27

0.355 (2.55%)

15:19
06/18/18
06/18
15:19
06/18/18
15:19
Periodicals
GameStop talks with PE firms after seeing takeover interest, Reuters says »

GameStop is holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

OFC

Corporate Office Properties

$27.36

-0.055 (-0.20%)

15:18
06/18/18
06/18
15:18
06/18/18
15:18
Conference/Events
Corporate Office Properties management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
06/18/18
06/18
15:17
06/18/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
06/18/18
06/18
15:16
06/18/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$14.27

0.355 (2.55%)

15:11
06/18/18
06/18
15:11
06/18/18
15:11
Hot Stocks
Breaking Hot Stocks news story on GameStop 

GameStop trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

HDP

Hortonworks

$19.96

0.86 (4.50%)

15:10
06/18/18
06/18
15:10
06/18/18
15:10
Options
Higher call activity in HortonNetworks as shares see relative strength »

Higher call activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:10
06/18/18
06/18
15:10
06/18/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

GME

GameStop

$14.29

0.375 (2.69%)

15:08
06/18/18
06/18
15:08
06/18/18
15:08
Hot Stocks
GameStop jumps after Reuters reports on takeover interest »

Shares of GameStop (GME)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

QTNT

Quotient

$8.33

1.2 (16.83%)

15:08
06/18/18
06/18
15:08
06/18/18
15:08
Conference/Events
Quotient management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

GME

GameStop

$14.30

0.385 (2.77%)

15:06
06/18/18
06/18
15:06
06/18/18
15:06
Periodicals
Breaking Periodicals news story on GameStop »

GameStop talks with PE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

GME

GameStop

$14.31

0.395 (2.84%)

15:05
06/18/18
06/18
15:05
06/18/18
15:05
Hot Stocks
Breaking Hot Stocks news story on GameStop »

GameStop trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

SKX

Skechers

$29.23

-0.2 (-0.68%)

15:05
06/18/18
06/18
15:05
06/18/18
15:05
Options
Skechers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CME

CME Group

$169.09

-0.7 (-0.41%)

14:55
06/18/18
06/18
14:55
06/18/18
14:55
Conference/Events
CME Group management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

  • 26

    Jul

BIG

Big Lots

$41.35

0.11 (0.27%)

14:55
06/18/18
06/18
14:55
06/18/18
14:55
Options
Big Lots put volume heavy and directionally bearish »

Bearish flow noted in Big…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJW

SJW Corp.

$66.69

-0.16 (-0.24%)

, CTWS

Connecticut Water

$65.50

0.5 (0.77%)

14:49
06/18/18
06/18
14:49
06/18/18
14:49
Hot Stocks
SJW sees giving shareholders chance to vote on Connecticut Water deal ASAP »

SJW Group (SJW) commented…

SJW

SJW Corp.

$66.69

-0.16 (-0.24%)

CTWS

Connecticut Water

$65.50

0.5 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTC

PTC

$98.07

3.2 (3.37%)

14:45
06/18/18
06/18
14:45
06/18/18
14:45
Recommendations
PTC analyst commentary  »

PTC price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

OXY

Occidental Petroleum

$84.23

0.9 (1.08%)

14:45
06/18/18
06/18
14:45
06/18/18
14:45
Options
Occidental Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$43.86

1.33 (3.13%)

14:41
06/18/18
06/18
14:41
06/18/18
14:41
Recommendations
Etsy analyst commentary  »

Etsy price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

BUD

AB InBev

$96.45

-2.05 (-2.08%)

14:37
06/18/18
06/18
14:37
06/18/18
14:37
Hot Stocks
AB InBev, Kiip launch blockchain mobile ad campaign »

Kiip and AB Inbev…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

GSKY

GreenSky

$24.15

-0.12 (-0.49%)

14:36
06/18/18
06/18
14:36
06/18/18
14:36
Initiation
GreenSky initiated  »

GreenSky initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXC

DXC Technology

$83.05

-0.805 (-0.96%)

14:34
06/18/18
06/18
14:34
06/18/18
14:34
Hot Stocks
SOLUTIONS 30, DXC sign strategic partnership in Italy »

SOLUTIONS 30 Italia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QD

Qudian

$9.50

0.01 (0.11%)

14:25
06/18/18
06/18
14:25
06/18/18
14:25
Options
Qudian Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
06/18/18
06/18
14:25
06/18/18
14:25
General news
More from Bostic: a possible yield curve inversion »

More from Bostic: a…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.